BENGALURU (Reuters) – Sun Pharmaceutical Industries posted a nearly 2% fall in its first-quarter profit on Thursday, hurt by a rise in expenses.
The company’s consolidated net profit after tax stood at 20.23 billion rupees ($244.4 million) for the quarter ended June 30, compared with 20.61 billion rupees a year earlier.
Analysts, on average, had expected a profit of 21.38 billion rupees, as per Refinitiv data.
($1 = 82.7825 Indian rupees)
(Reporting by Rishika Sadam in Hyderabad and Kashish Tandon in Bengaluru; Editing by Nivedita Bhattacharjee)
